CDC Website CDC Website

To Join the NPIN community or

Home » Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional)

COVID-19 Information |

For COVID-19 testing information please visit: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

Directly contact organizations to find out about changes to services or hours.

Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional)

The purpose of this funding opportunity announcement (FOA) is to encourage research focused on tobacco use and human immunodeficiency virus (HIV) infection in low and middle income countries (LMICs). In particular, applications are encouraged that focus on the development and evaluation of tobacco cessation interventions tailored to HIV positive populations, including those with co-morbidities such as tuberculosis (TB), in low-resource settings in LMICs. This FOA provides funding for research planning, intervention delivery, and follow-up activities.

Letter of Intent Date
8/24/20
Application Due Date
9/24/20
Project Start Date
7/1/21
Application Contact
Dawn
Mitchum
Team Leader, Grants Portfolio Management Branch B
240-276-5699
dm437a@nih.gov
Technical Contact
Mark .
Parascandola, Ph.D.
Epidemiologist
Mark.Parascandola@nih.gov
240-276-6871
Fund Duration
The maximum project period is 5 years.
Subjects
Audiences

Fund Number: 

347083

Fund ID: 

RFA-CA-20-037

Last modified: 

7/8/20